A., Servan-Schreiber, D., Panchalingam, K., & McClure, R
Sudden worsening of nausea after initially improving may indicate a medication interaction, underlying gastrointestinal condition, or dose-related issue that needs adjustment
However, some transporters, including OATP1B1/3 and OAT3, demonstrated inhibition following treatment with GLP-1 RAs and a dual GLP-1/GIP RA in vitro, suggesting that the assessment of transporter-mediated DDI by GLP-1 RAs may be necessary (Table 3)
20 In 2017, opioids were involved in 50% of methamphetamine-involved deaths, and recent data suggests synthetic opioids are driving increases in methamphetamine-involved deaths
#ATTD2026 #FreeDM2 #Type2Diabetes #CGM #UKHealthcare #NHS #PatientEmpowerment #ClinicalEvidence #AbbottProud To view or add a comment, sign in A clinical trial for diabetes that pit orforglipron, a diabetes and weight-loss pill developed by Eli Lilly, against oral semaglutide, made by Novo Nordisk, suggests the former pill may have the edge in reducing blood sugar and weight